Apoptosis Antagonizing Transcription Factor (AATF) (C-Term) Peptid
AATF
Reaktivität: Human
BP
Sodium azide
Produktnummer ABIN1382122
-
-
Target
Alle AATF Produkte
-
AATF
(Apoptosis Antagonizing Transcription Factor (AATF))
-
Protein Region
-
C-Term
-
Spezies
-
Human
-
Applikation
-
Blocking Peptide (BP)
-
Produktmerkmale
-
12 amino acids near the carboxy terminus of human AATF.
Human
-
-
-
Applikationshinweise
-
AATF peptide is used for blocking the activity of AATF.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Haltbarkeit
-
12 months
-
-
Target
-
AATF
(Apoptosis Antagonizing Transcription Factor (AATF))
-
Synonyme
-
AATF Peptide, ded Peptide, che1 Peptide, che-1 Peptide, cb109 Peptide, sb:cb109 Peptide, wu:fc13d05 Peptide, zgc:162071 Peptide, CHE-1 Peptide, CHE1 Peptide, DED Peptide, 4933415H02Rik Peptide, 5830465M17Rik Peptide, Che-1 Peptide, Trb Peptide, Ded Peptide, apoptosis antagonizing transcription factor Peptide, Apoptosis antagonizing transcription factor Peptide, apoptosis antagonizing transcription factor S homeolog Peptide, AATF Peptide, aatf Peptide, BFR2 Peptide, NAEGRDRAFT_56916 Peptide, Aatf Peptide, aatf.S Peptide
-